SLC27A3 downregulation restores Th17/Treg balance and alleviates COPD via JAK2/STAT3 pathway inhibition
Main Article Content
Keywords
chronic obstructive pulmonary disease, solute carrier family 27 member 3, JAK2/STAT3, Th17/Treg balance, inflammatory response, cigarette smoke
Abstract
The main goal of this investigation is to find out how solute carrier family 27 member 3 (SLC27A3) is expressed in the lung tissue of mice with chronic obstructive pulmonary disease (COPD), and how it relates to lung function. A model of COPD was established by exposing organisms to cigarette smoke, followed by investigating the role of SLC27A3 in COPD through experiments conducted both in living organisms and in laboratory settings. Knockout mice lacking SLC27A3 were produced through siRNA transfection to investigate lung function and inflammatory response, using methods such as hematoxylin-eosin staining and enzyme-linked immunosorbent assay. Western blotting was carried out to analyze the expression of SLC27A3. Naïve CD4+ T-cells were stimulated with anti-CD3, anti-CD28, transforming growth factor (TGF)-β, and/or interleukin (IL)-6, and their differentiation into Th17 or Treg cells was promoted, as assessed by flow cytometry. The pathway expression of JAK2/STAT3 was detected using Western blotting. Mice with COPD that had higher expression levels of SLC27A3 in their lung tissue display abnormalities in lung architecture and function, as well as an imbalance between Th17 and Tregs and an elevated inflammatory response. In COPD mice with SLC27A3 knockdown, the JAK2/STAT3 pathway was repressed, lung inflammation was decreased, Th17/Treg balance was improved, and lung functioning was improved. In conclusion, the findings of this study suggest that downregulating SLC27A3 has the potential to attenuate the inflammatory response, mitigate COPD progression, and rebalance the Th17/Treg ratio by inhibiting the JAK2/STAT3 signaling pathway. These results lay a foundation for utilizing SLC27A3 as a potential therapeutic target to modulate the JAK2/STAT3 pathway for the treatment of COPD, with the aim of enhancing lung function, reducing inflammation, and restoring Th17/Treg equilibrium in a clinical context.
References
2 Lu Z, Van Eeckhoutte HP, Liu G, Nair PM, Jones B, Gillis CM, et al. Necroptosis signaling promotes inflammation, airway remodeling, and emphysema in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2021;204(6):667–81. 10.1164/rccm.202009-3442OC
3 Song H, Jiang L, Yang W, Dai Y, Wang Y, Li Z, et al. Cryptotanshinone alleviates lipopolysaccharide and cigarette smoke-induced chronic obstructive pulmonary disease in mice via the Keap1/Nrf2 axis. Biomed Pharmacother. 2023;165:115105. 10.1016/j.biopha.2023.115105
4 Villasenor-Altamirano AB, Jain D, Jeong Y, Menon JA, Kamiya M, Haider H, et al. Activation of CD8(+) T cells in chronic obstructive pulmonary disease lung. Am J Respir Crit Care Med. 2023;208(11):1177–95. 10.1164/rccm.202305-0924OC
5 Lourenco JD, Ito JT, Martins MA, Tiberio I, Lopes F. Th17/Treg imbalance in chronic obstructive pulmonary disease: Clinical and experimental evidence. Front Immunol. 2021;12:804919. 10.3389/fimmu.2021.804919
6 Thomas R, Qiao S, Yang X. Th17/Treg imbalance: Implications in lung inflammatory diseases. Int J Mol Sci. 2023;24(5). 10.3390/ijms24054865
7 Silva LEF, Lourenco JD, Silva KR, Santana FPR, Kohler JB, Moreira AR, et al. Th17/Treg imbalance in COPD development: Suppressors of cytokine signaling and signal transducers and activators of transcription proteins. Sci Rep. 2020;10(1):15287. 10.1038/s41598-020-72305-y
8 Zhang Y, Xia R, Lv M, Li Z, Jin L, Chen X, et al. Machine-learning algorithm-based prediction of diagnostic gene biomarkers related to immune infiltration in patients with chronic obstructive pulmonary disease. Front Immunol. 2022;13:740513. 10.3389/fimmu.2022.740513
9 Viraragavan A, Willmer T, Patel O, Basson A, Johnson R, Pheiffer C. Cafeteria diet induces global and Slc27a3-specific hypomethylation in male Wistar rats. Adipocyte. 2021;10(1):108–18. 10.1080/21623945.2021.1886697
10 Maekawa M, Iwayama Y, Ohnishi T, Toyoshima M, Shimamoto C, Hisano Y, et al. Investigation of the fatty acid transporter-encoding genes SLC27A3 and SLC27A4 in autism. Sci Rep. 2015;5:16239. 10.1038/srep16239
11 Niculae AM, Dobre M, Herlea V, Vasilescu F, Ceafalan LC, Trandafir B, et al. Lipid handling protein gene expression in colorectal cancer: CD36 and targeting miRNAs. Life (Basel). 2022;12(12). 10.3390/life12122127
12 Korbecki J, Kojder K, Jezewski D, Siminska D, Tomasiak P, Tarnowski M, et al. Reduced expression of very-long-chain Acyl-CoA synthetases SLC27A4 and SLC27A6 in the glioblastoma tumor compared to the peritumoral area. Brain Sci. 2023;13(5). 10.3390/brainsci13050771
13 Pecka-Kielb E, Kowalewska-Luczak I, Czerniawska-Piatkowska E, Zielak-Steciwko AE. Effects of single nucleotide polymorphisms in the SLC27A3 gene on the nutritional value of sheep milk. Animals (Basel). 2020;10(4). 10.3390/ani10040562
14 Xu YQ, Lv W, Wu HJ, Shi S. Ginsenoside regulates Treg/Th17 cell ratio and inhibits inflammation to treat COPD. Pharmazie. 2020;75(11):590–4.
15 Uwagboe I, Adcock IM, Lo Bello F, Caramori G, Mumby S. New drugs under development for COPD. Minerva Med. 2022; 113(3):471–96. 10.23736/S0026-4806.22.08024-7
16 Kahnert K, Jorres RA, Behr J, Welte T. The diagnosis and treatment of COPD and its comorbidities. Dtsch Arztebl Int. 2023;120(25):434–44. 10.3238/arztebl.m2023.0027
17 Guo P, Li R, Piao TH, Wang CL, Wu XL, Cai HY. Pathological mechanism and targeted drugs of COPD. Int J Chron Obstruct Pulmon Dis. 2022;17:1565–75. 10.2147/COPD.S366126
18 Fu YS, Kang N, Yu Y, Mi Y, Guo J, Wu J, et al. Polyphenols, flavonoids and inflammasomes: The role of cigarette smoke in COPD. Eur Respir Rev. 2022;31(164). 10.1183/16000617.0028-2022
19 Kaur M, Chandel J, Malik J, Naura AS. Particulate matter in COPD pathogenesis: An overview. Inflamm Res. 2022;71(7-8):797–815. 10.1007/s00011-022-01594-y
20 Su X, Wu W, Zhu Z, Lin X, Zeng Y. The effects of epithelial-mesenchymal transitions in COPD induced by cigarette smoke: An update. Respir Res. 2022;23(1):225. 10.1186/s12931-022-02153-z
21 Cheng Q, Fang L, Feng D, Tang S, Yue S, Huang Y, et al. Memantine ameliorates pulmonary inflammation in a mice model of COPD induced by cigarette smoke combined with LPS. Biomed Pharmacother. 2019;109:2005–13. 10.1016/j.biopha.2018.11.002
22 Wang Y, Liao S, Pan Z, Jiang S, Fan J, Yu S, et al. Hydrogen sulfide alleviates particulate matter-induced emphysema and airway inflammation by suppressing ferroptosis. Free Radic Biol Med. 2022;186:1–16. 10.1016/j.freeradbiomed.2022.04.014
23 Pan D, Ye H, Wang J, Mao J. Gentianine facilitates proliferation and inhibits inflammation and oxidative stress in caerulein-triggered acute pancreatitis cell model. Signa Vitae 2024;20(5).
24 Zhao P, Liu X, Dong H, Tian Y, Feng S, Zhao D, et al. Bufei Yishen formula restores Th17/Treg balance and attenuates chronic obstructive pulmonary disease via activation of the adenosine 2a receptor. Front Pharmacol. 2020;11:1212. 10.3389/fphar.2020.01212
25 Lopes F, Tiberio I, Leme A, Fairclough L. Editorial: The importance of Th17/Treg imbalance in asthma and COPD development and progression. Front Immunol. 2022;13:1025215. 10.3389/fimmu.2022.1025215
26 Milara J, Ballester B, de Diego A, Calbet M, Ramis I, Miralpeix M, et al. The pan-JAK inhibitor LAS194046 reduces neutrophil activation from severe asthma and COPD patients in vitro. Sci Rep. 2022;12(1):5132. 10.1038/s41598-022-09241-6
27 Wang L, Yuan N, Li Y, Ma Q, Zhou Y, Qiao Z, et al. Stellate ganglion block relieves acute lung injury induced by severe acute pancreatitis via the miR-155-5p/SOCS5/JAK2/STAT3 axis. Eur J Med Res. 2022;27(1):231. 10.1186/s40001-022-00860-3
28 Silverman EK. Genetics of COPD. Annual review of physiology. 2020;82(1):413–31.
